These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30861639)

  • 1. Catalpol ameliorates advanced glycation end product-induced dysfunction of glomerular endothelial cells via regulating nitric oxide synthesis by inducible nitric oxide synthase and endothelial nitric oxide synthase.
    Sun W; Gao Y; Ding Y; Cao Y; Chen J; Lv G; Lu J; Yu B; Peng M; Xu H; Sun Y
    IUBMB Life; 2019 Sep; 71(9):1268-1283. PubMed ID: 30861639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalpol Prevents Glomerular Angiogenesis Induced by Advanced Glycation End Products via Inhibiting Galectin-3.
    Sun WX; Gao YY; Cao Y; Lu JF; Lv GH; Xu HQ
    Curr Med Sci; 2023 Aug; 43(4):668-678. PubMed ID: 37480413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway.
    Shu A; Du Q; Chen J; Gao Y; Zhu Y; Lv G; Lu J; Chen Y; Xu H
    Chem Biol Interact; 2021 Oct; 348():109625. PubMed ID: 34416245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells.
    Choi HJ; Jang HJ; Chung TW; Jeong SI; Cha J; Choi JY; Han CW; Jang YS; Joo M; Jeong HS; Ha KT
    Fitoterapia; 2013 Apr; 86():19-28. PubMed ID: 23376161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway.
    Ho FM; Lin WW; Chen BC; Chao CM; Yang CR; Lin LY; Lai CC; Liu SH; Liau CS
    Cell Signal; 2006 Mar; 18(3):391-9. PubMed ID: 15970429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
    Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
    Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
    Ren X; Ren L; Wei Q; Shao H; Chen L; Liu N
    Cardiovasc Diabetol; 2017 Apr; 16(1):52. PubMed ID: 28427390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of incretin agonists on endothelial nitric oxide synthase expression and nitric oxide synthesis in human coronary artery endothelial cells exposed to TNFα and glycated albumin.
    Garczorz W; Francuz T; Siemianowicz K; Kosowska A; Kłych A; Aghdam MR; Jagoda K
    Pharmacol Rep; 2015 Feb; 67(1):69-77. PubMed ID: 25560578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
    Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
    Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
    Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxidasin promotes diabetic vascular endothelial dysfunction induced by advanced glycation end products via NOX2/HOCl/Akt/eNOS pathway.
    Jing Cao ; Zhang G; Liu Z; Xu Q; Li C; Cheng G; Shi R
    Redox Biol; 2021 Sep; 45():102031. PubMed ID: 34116361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells.
    Feliers D; Chen X; Akis N; Choudhury GG; Madaio M; Kasinath BS
    Kidney Int; 2005 Oct; 68(4):1648-59. PubMed ID: 16164642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation.
    Franceschelli S; Pesce M; Ferrone A; Gatta DM; Patruno A; Lutiis MA; Quiles JL; Grilli A; Felaco M; Speranza L
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide suppresses cisplatin-induced endothelial hyperpermeability through activation of PI3K/Akt and eNOS -derived nitric oxide.
    Bodiga VL; Bathula J; Kudle MR; Vemuri PK; Bodiga S
    Bioorg Med Chem; 2020 Dec; 28(23):115809. PubMed ID: 33065471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
    Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
    Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells.
    Hu H; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Liu X; Sun H
    Inflammation; 2019 Feb; 42(1):64-80. PubMed ID: 30315526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Glycation End-Products Downregulate HoxA9EC through Activation of Nuclear Factor Kappa B by Reciprocal Interaction.
    Zhu QQ; Li DL; He YY; Wu ZH; Tian L; Zheng CF; Zhang N; Zhang HK
    J Vasc Res; 2017; 54(4):226-234. PubMed ID: 28723696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
    Soro-Paavonen A; Zhang WZ; Venardos K; Coughlan MT; Harris E; Tong DC; Brasacchio D; Paavonen K; Chin-Dusting J; Cooper ME; Kaye D; Thomas MC; Forbes JM
    J Hypertens; 2010 Apr; 28(4):780-8. PubMed ID: 20186099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of LY294002 and wortmannin on inducible nitric oxide synthase expression in glomerular mesangial cells.
    Tsai KD; Chang WW; Lin CC; Hsu SC; Lee YJ; Chen W; Shieh JC; Lin TH
    Int Immunopharmacol; 2012 Mar; 12(3):471-80. PubMed ID: 22240122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.